Biologically active pentacyclic triterpenes and their current medicine signification

Journal of Applied Biomedicine

Volumn 10, Issue 3, 2012, Pages 7-12

  Patočka, Jiří ^a  

^a UNIVERSITY OF SOUTH BOHEMIA   (Czech Republic)

Author keywords

Betuline; Betulinic acid; Biological activity; Lupeol; Pentacyclic triterpene

Indexed keywords

ACETYLSALICYLIC ACID; BETULIC ACID; BETULIN; CAMPTOTHECIN; DEXAMETHASONE; ETOPOSIDE; GAMMACERANE; HOPANE; LUPEOL; PENTACYCLIC TRITERPENE; PHENYLBUTAZONE; TRITERPENE; UNCLASSIFIED DRUG; URSANE; VINBLASTINE; VINCRISTINE;

ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIVIRAL ACTIVITY; APOPTOSIS; ARTHRITIS; ARTICLE; CANCER CELL; DRUG STRUCTURE; EDEMA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; INFLAMMATION; MELANOMA; NONHUMAN; PAW EDEMA; VIRUS REPLICATION;

EID: 84863823475     PISSN: 1214021X     EISSN: 12140287     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. De Clercq E.: Novel compounds in preclinical/early clinical development for the treatment of HIV infections. Rev Med Virol 10:255-277. 2000; Erratum in: Rev Med Virol 10:349, 2000.
2. Fernandez M.A., B. de las Heras, M.D. Garcia M.T. Saenz, A. Villar: New insights into the mechanism of action of the anti-inflammatory triterpene lupeol. J Pharm Pharmacol 53:1533-1539, 2001.
3. Fulda S., I. Jeremias, H.H. Steiner, T. Pietsch, K.M. Debatin: Betulinic acid: a new cytotoxic agent against malignant brain-tumor cells. Int J Cancer 82:435-441, 1999.
4. Fulda S., S.A. Susin, G. Kroemer, K.M. Debatin: Molecular ordering of apoptosis induced by anticancer drugs in neuroblastoma cells. Cancer Res 58:4453-4460, 1999.
5. Geetha T., P. Varalaxmi: Anti-inflammatory activity of lupeol and lupeol linoleate in adjuvant-induced arthritis. Fitoterapia 69: 13-19, 1998.
6. González-Coloma A., M. Reina, B.M. Frga, C. Gutiérrez, C.L. Balboa: Bioactive Lupeol from Senecio heritieri structure-activity relationship. Conference of the International Society of Chemical Ecology, Marseille 1999; Abstract p. 44.
7. Hashimoto F., Y. Kashiwada, L.M. Cosentino, C.H. Chen, P.E. Garrett, K.H. Lee: Anti-AIDS agents-XXVII. Synthesis and anti-HIV activity of betulinic acid and dihydrobetulinic acid derivatives. Bioorg Med Chem 5:2133-2143, 1997.
8. Huang C., H. Tunon, L. Bohlin: Anti-inflammatory compounds isolated from Menyanthes trifoliata L. Yao Xue Xue Bao 30:621-626, 1995.
9. Kanamoto T., Y. Kashiwada, K. Kanbara, K. Gotoh, M. Yoshimori, T. Goto, K. Sano, H. Nakashima: Antihuman immunodeficiency virus activity of YK-FH312 (a betulinic acid derivative), a novel compound blocking viral maturation. Antimicrob Agents Chemother 45:1225-1230, 2001.
10. Kashiwada Y., J. Chiyo, Y. Ikeshiro, T. Nagao, H. Okabe, L.M. Cosentino, K. Fowke, S.L. Morris-Natschke, K.H. Lee: Synthesis and anti-HIV activity of 3-alkylamido-3-deoxy-betulinic acid derivatives. Chem Pharm Bull (Tokyo) 48:1387-1390, 2000.
11. Kashiwada Y., F. Hashimoto, L.M. Cosentino, C.H. Chen, P.E. Garrett, K.H. Lee: Betulinic acid and dihydrobetulinic acid derivatives as potent anti-HIV agents. J Med Chem 39:1016-1017, 1996.
12. Kweifio-Okai G., F. de Munk., T.A. Macrides., P. Smith, B.A. Rumble: Anti-arthritic mechanisms of Lupeol Triterpenes. Drug Develop Research 36: 20-24, 1995.
13. Ma C., N. Nakamura, H. Miyashiro, M. Hattori, K. Shimotohno: Inhibitory effects of constituents from Cynomorium songaricum and related triterpene derivatives on HIV-1 protease. Chem Pharm Bull (Tokyo) 47:141-145, 1999.
14. Min B.S., J.J. Gao, N. Nakamura, M. Hattori: Triterpenes from the spores of Ganoderma lucidum and their cytotoxicity against meth-A and LLC tumor cells. Chem Pharm Bull (Tokyo) 48:1026-1033, 2001.
15. Nagumo A., K. Takanashi, H. Hojo, Y. Suzuki: Cytotoxicity of bacteriohopane-32-ol against mouse leukemia L1210 and P388 cells in vitro. Toxicol Lett 58:309-313, 2001.
16. Najid A., A. Simon, J. Cook, H. Chable-Rabinovitch, C. Delage, A.J. Chulia, M. Rigaud: Characterization of ursolic acid as a lipoxygenase and cyclooxygenase inhibitor using macrophages, platelets and differentiated HL60 leukemic cells. FEBS Lett 299:213-217, 1992.
17. Novotny L., A. Vachalkova, D. Biggs: Ursolic acid: an antitumorigenic and chemopreventive activity. Neoplasma 48:241-246, 2001.
18. Olukoga A., D. Donaldson: Liquorice and its health implications. J R Soc Health 120:83-89, 2000.
19. Patočka J: Antiinflammatory triterpenoids from mysterious muscroom Ganoderma lucidum and their potential possibility in modern medicine. Acta Medica (Hradec Kralove) 42:123-125, 1999.
20. Pisha E., H. Chai, I.S. Lee, T.E. Chagwedera, N.R. Farnsworth, G.A. Cordell, C.W. Beecher, H.H. Fong, A.D. Kinghorn, D.M. Brown et al.: Discovery of betulinic acid as a selective inhibitor of human melanoma that functions by induction of apoptosis. Nat Med 1:1046-1051, 1995.
21. Rajic A., G. Kweifio-Okai, T. Macrides, R.M. Sandeman, D.S. Chandler, G.M. Polya: Inhibition of serine proteases by anti-inflammatory triterpenoids. Planta Med 66:206-210, 2000.
22. Recio M.C., R.M. Giner, S. Manez, J.L. Rios: Structural requirements for the anti-inflammatory activity of natural triterpenoids. Planta Med 61:182-185, 1995.
23. Rieber M., M. Strasberg Rieber: Induction of p53 without increase in p21WAF1 in betulinic acid-mediated cell death is preferential for human metastatic melanoma. DNA Cell Biol 17:399-406, 1998.
24. Salti G.I., J.V. Kichina, T.K. Das Gupta, S. Uddin, L. Bratescu, J.M. Pezzuto, R.G. Mehta, A.I. Constantinou: Betulinic acid reduces ultraviolet-C-induced DNA breakage in congenital melanocytic naeval cells: evidence for a potential role as a chemopreventive agent. Melanoma Res 11:99-104, 2001.
25. Schmidt M.L., K.L. Kuzmanoff, L. Ling-Indeck, J.M. Pezzuto: Betulinic acid induces apoptosis in human neuroblastoma cell lines. Eur J Cancer 33:2007-2010, 1997.
26. Selzer E., E. Pimentel, V. Wacheck, W. Schlegel, H. Pehamberger, B. Jansen, R. Kodym: Effects of betulinic acid alone and in combination with irradiation in human melanoma cells. J Invest Dermatol 114:935-940, 2000.
27. Simoes C.M., M. Amoros, L. Girre: Mechanism of antiviral activity of triterpenoid saponins. Phytother Res 13:323-328, 1999.
28. Singh G.B., S. Singh, S. Bani, B.D. Gupta, S.K. Banerjee: Antiinflammatory activity of oleanolic acid in rats and mice. J Pharm Pharmacol 44:456-458, 1992.
29. Sirtori C.R. Aescin: pharmacology, pharmacokinetics and therapeutic profile. Pharmacol Res 44:183-193, 2001.
30. Soler F., C. Poujade, M. Evers, J. C. Carry, Y. Henin, A. Bousseau, T. Huet, R. Pauwels, E. De Clercq, J.F. Mayaux, J.B. Le Pecq, N. Dereu: Betulinic acid derivatives: a new class of specific inhibitors of human immunodeficiency virus type 1 entry. J Med Chem 39:1069-1083, 1996.
31. Subhadhirasakul S., H. Takayama, F.M. Kitajima, N.F. Aimi: Triterpenoids from Thai medicinal plant, Willughbeia firma. Natural Med 54: 155-157, 2000.
32. Szakiel A., I. Wasiukiewicz, W. Janiszowska: Metabolism of [3-3H]oleanolic acid in the isolated Calendula officinalis leaf cells and transport of the synthesized glycosides to the cell wall and the extracellular space. Acta Biochim Pol 42:25-29, 1995.
33. Takeoka G., L. Dao, R. Teranishi, R. Wong, S. Flessa, L. Harden, R. Edwards: Identification of three triterpenoids in almond hulls. J Agric Food Chem 48:3437-3439, 2000.
34. Zuco V., R. Supino, S.C. Righetti, L. Cleris, E. Marchesi, C. Gambacorti-Passerini, F. Formelli: Selective cytotoxicity of betulinic acid on tumor cell lines, but not on normal cells. Cancer Lett 175:17-25, 2002.